CNP and Myocardial fibrosis: Because the effects of fibroblast GC-B inhibition were evaluated after 2 weeks of neurohumoral (Ang II) stimulation or pressure overload (TAC), for future clinical application, further studies are necessary to examine whether the effects of endogenous CNP on myocardial fibrosis persist for longer-term follow-up periods.